Regeneron Pharmaceuticals Inc. (REGN) shares surged 6.17% to $738.34, significantly outperforming its competitors during a strong trading day. This marks the stock's sixth consecutive day of gains, potentially driven by positive company news or sector momentum.

Regeneron Shares Climb 6.17%, Outperform Peers
pharmaceuticalsstock-performancebiotechRegeneron

